Zhubin J. Gahvari, MD, MS, and Natalie S. Callander, MD, provide a comprehensive overview of current treatment paradigms in relapsed and refractory multiple myeloma.
Zhubin J. Gahvari, MD, MS
Advertisement
Articles by Zhubin J. Gahvari, MD, MS
Advertisement
Latest Updated Articles
The Management of Relapsed and Refractory Multiple MyelomaPublished: April 26th 2023 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves SC Pembrolizumab Formulation in Solid Tumors
2
Daratumumab Quadruplet Improves Efficacy in Transplant-Ineligible or-Deferred, Newly Diagnosed Myeloma
3
Sonrotoclax Combo Shows Safety, Promising Efficacy in R/R Multiple Myeloma
4
Belantamab Mafodotin Triplet Highlights Low Ocular Toxicity in Intermediate-Fit, Frail Newly Diagnosed Myeloma
5
